Commercial Helicopter Market Worth $6.9 Billion By 2025

The global commercial helicopter market size is expected to reach USD 6.92 billion by 2025, registering a CAGR of 3.8% over the forecast period, according to a new report by Grand View Research, Inc. Factors such as the growth in oil and gas exploration activities and rising demand for air ambulances in medical evacuation are expected to drive the market. Increasing popularity of rotorcraft for commercial applications in the countries from Middle East and Asia Pacific coupled with its success in western countries, is anticipated the further propel the growth.

Noticeable rise in the purchase of new helicopters for tourism, training, law enforcement, and firefighting applications, particularly as a result of the continued replacement of older fleets and the widening application base is expected to bode well for the market growth. In the transportation domain, the demand for luxurious and customized helicopters is increasing at a rapid pace. The popularity of personalized chartered helicopters is expected to increase in line with the growing preference for enhanced comfort and luxury among the high-end business travelers.

Rising demand for fuel-efficient rotorcraft, expiring warranties, and changes in operational requirements are some of the key factors anticipated to drive the demand for new helicopters over the forecast period. Commercial fleet operators purchase new helicopters based on various parameters, such as performance, range, cabin size, technology upgrades, and brand experience. Rapid infrastructural development and airline deregulation in emerging countries across the world is expected to offer immense opportunity for the sale of rotorcraft.

The North America commercial helicopter market is anticipated to experience substantial growth during the forecast period owing to the rising demand for rotorcraft in oil and gas and renewable energy industries. The market in Asia Pacific was valued at more than a billion dollar in 2018 and is projected to expand at a CAGR of approximately 6% over the forecast period. Countries, such as India and China, are expected to emerge as some of the fastest-growing markets due to the relaxation of airspace regulations and growth in the regional aviation sector.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/commercial-helicopters-market

Further key findings from the report suggest:

Increasing demand for advanced rotorcraft for law enforcement, public safety, and other parapublic applications is expected to offer numerous opportunities for market growth
Rising adoption of stringent regulatory policies regarding emissions and noise pollution in developed economies, such as U.S., is encouraging manufacturers to develop low-noise and environmentally friendly rotorcraft
Key manufacturers are expected to reduce their delivery and production rates to support secondary markets; manufacturing aircrafts that are easier to re-configure for various applications
Middle East and Africa is emerging as a new frontier for the global market as the regional governments are increasingly seeking replacement of older fleet with advanced rotorcraft
The R&D activities are expected to create significant growth opportunities for the companies specializing in the development of advanced rotorcraft, such as optionally-piloted rotorcraft, tilt rotorcraft, and the ones with co-axial rotors

Allergy Diagnostics & Therapeutics Market Worth $51.95 Billion By 2026

The global allergy diagnostics and therapeutics market size is expected to reach USD 51.95 billion by 2026 registering a CAGR of 6.3%, according to a new study by Grand View Research, Inc. Increasing prevalence of allergic conditions coupled with adoption of immunoassay as diagnostic test is expected to serve this market with lucrative growth opportunities. According to the report published by the World Allergy Journal in May 2014, around 300 million cases of asthma and 200 to 250 million cases of food allergies were reported. This number is expected to increase over the forecast period due to sedentary lifestyle and poor dietary habits.

cropped view of doctor in white coat and latex gloves holding marker pen near marked female hand

Rising industrial pollution, rapid urbanization in developing countries, and increasing Greenhouse Gas (GHG) concentrations are expected to result in increased prevalence of pollen induced respiratory disorder, thereby boosting the overall market growth over the forecast period. Emergence of technologically advanced products, such as MeDALL allergen-chip for allergy determination, is further expected to propel the market growth in the years to come.

The global market is highly competitive and is led by companies including Thermo Fisher Scientific, Omega Diagnostics, Siemens Healthcare, Stallergenes Greer, Lincoln Diagnostics, bioMerieux, HOB Biotech Group, Alcon Laboratories, Hycor Biomedical, and Hitachi Chemical Diagnostics. Most of the industry participants focus on the development of advanced products and technologies to gain competitive advantage. For instance, in March 2015, Stallergenes received approval for STG 320 in Japan, which is the first sublingual immunotherapy tablet used in the treatment of house dust mite allergy.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/allergy-diagnostic-market

Further key findings from the study suggest:

Instruments product segment is anticipated to witness the highest CAGR of 12.2% from 2019 to 2025 due to high demand for analyzers and laminators for allergy diagnostics
In vitro is expected to be the largest as well as fastest-growing test segment over the estimated period on account of rising demand for minimally invasive and allergen-specific tests
Antihistamines drug class led the allergy diagnostics and therapeutics market in 2018 due to its advantages, such as non sedating nature and minimum side effects with use of second generation antihistamines in allergy treatment
Immunotherapy vaccines is expected to register the maximum CAGR from 2019 to 2025 owing to extensive R&D in the field and advent of sublingual immunotherapy tablets in the treatment of allergic rhinitis
For instance, in April 2014, the U.S. FDA approved a five-grass pollen sublingual tablet (Ex-Oralair) by Stallergenes, which is used in the treatment of pollen allergy

Auto-injectors Market Size Worth $3.2 Billion by 2026

The global auto-injectors market size is expected to reach USD 3.18 billion by 2026, according to a new report by Grand View Research, Inc, exhibiting a CAGR of 19.5%. Rising incidence of anaphylactic shock and other diseases such as diabetes, rheumatoid, & multiple sclerosis along with increasing approvals of auto-injectors are impelling growth.

Increasing prevalence of life-threatening allergies and rising demand for these devices are expected to aid growth. As per the Food Allergy Research & Education, around 200, 000 people every year need emergency medical care for allergic food reactions.

In addition, increasing approvals are anticipated to drive growth. For instance, in August 2018, U.S. FDA approved the first generic epinephrine auto-injector of Teva Pharmaceuticals to treat emergency allergic reactions, including anaphylaxis. Generic versions of EpiPen Jr & EpiPen of 0.15 mg & 0.3 mg, respectively, are indicated for pediatric and adult patients weighing more than 33 pounds.

Moreover, manufacturers are also developing new products and innovative technologies, which is expected to propel market growth. For instance, in June 2018, AbbVie GK launched Humira, which is a fully human antitumor necrosis factor alpha monoclonal antibody formulation with lock function & injection start & end alerts as well as an inspection window and injects completely in 10 seconds. Demand for these devices is increasing as they are designed in accordance with patient acceptance and compliance. Technological advancements are anticipated to make them more convenient and user-friendly. This is encouraging patients to adopt this technology for chronic illnesses.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/auto-injectors-market

Further key findings from the study suggest:

Disposable auto-injectors emerged as the largest segment owing to convenience and ease of use
Homecare settings accounted for largest share in end-use segment owing to increasing demand of products for daily administration of insulin
North America dominated the auto-injectors market with largest share in 2018. Increasing demand for new technologies along with advanced healthcare infrastructure is expected to boost market growth during the forecast period
Asia Pacific is expected to witness fastest growth during the forecast period owing to increasing number of diabetic patients
Some of the key players are Eli Lilly; Scandinavian Health Ltd.; AbbVie, Inc.; Amgen; Owen Mumford; Ypsomed; Teva Pharmaceutical; Biogen Idec; Mylan N.V.; Pfizer, Inc.; and Sanofi

Fetal And Neonatal Care Equipment Market Worth $10.6 Billion By 2026

The global fetal (labor & delivery) and neonatal care equipment market size is expected to reach USD 10.6 billion by 2026 expanding at a CAGR of 6.9%, based on a new report by Grand View Research, Inc. Fetal and neonatal care devices consist of a variety of equipment that are designed to monitor and detect complications in newborn babies. The market growth can be attributed to factors such as a growing birthrate in developing countries coupled with rising prevalence of associated premature births also known as preemies.

Furthermore, neonatal hospital-acquired infections such as Central Line-Associated Bloodstream Infections (CLABSI) and healthcare-associated pneumonia are additional notable factors responsible for the market growth. Various aspects such as delayed maternal age, induced fertility, and lack of proper prenatal care are considered to be major factors contributing to the birth of premature babies.

According to the WHO estimates, 15 million neonates are born annually and a million were reported to die from preterm birth complications in 2015. To address the complications associated with babies born prematurely, the demand for fetal and neonatal care equipment is expected to rise significantly. In addition, consequences of supportive government policies coupled with rapid technological advancements in modern fetal and neonatal medical equipment is expected to contribute for growth in the long term.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/fetal-labor-and-delivery-and-neonatal-equipment-market

Further key findings from the study suggest:

Fetal care equipment accounted for the largest share of the market in 2018, however neonatal care equipment is expected to grow at a rapid rate during the forecast period.
Increasing complications during birth, increasing number of separate facilities for fetal & newborn care, and technological advancement in the fetal & neonatal care field are the key driving factors of the market. For instance, in February 2019, the University of Chicago Medicine launched Fetal and Neonatal Care Center (FNCC). The center offers one stop access to various specialists.
North America held the largest share in the fetal and neonatal care equipment market in 2018 due to the high awareness about neonatal and fetal care along with large number of neonatal intensive care unit (NICU) admissions.
The Asia Pacific region is projected to grow at the highest rate during the forecast period owing to aspects such as high birth rate in some Asia Pacific countries such as India & China and rising awareness programs for the improvement of fetal care & neonatal care.
In July 2013, largest Neonatal Intensive Care Unit in Southeast Asia became operational in Singapore. The facility is equipped with advanced equipment and technology.
The major players operating in the global fetal and neonatal care equipment market include Becton, Dickinson and Company, GE Healthcare, Koninklijke Philips N.V, THE DRAGER GROUP, Natus Medical Incorporated, Masimo Corporation, and Medtronic.
Mergers & collaborations and product development are the key strategies being undertaken by the market players. For instance, in June 2019 Clinical Computer Systems, Inc. entered into an agreement with Huntleigh Healthcare Limited to commercialize OBIX BeCA, a fetal monitor, in the U.S.

Orthopedic Biomaterials Market Size Worth $23.5 Billion By 2025

The global orthopedic biomaterials market size is expected to reach USD 23.5 billion by 2025 registering a CAGR of 10.3%, according to a new report by Grand View Research, Inc. Increasing incidence of degenerative joint disease and musculoskeletal disorders is the key factor driving the market. In addition, increasing geriatric population susceptible to orthopedic conditions arising due to low bone density and advancing bone related disorders is expected to boost the product demand over the forecast period.

Ceramics & bioactive glass was the dominant material type segment in 2018 on account of growing demand for these materials due to their high compression strength. In addition, ceramics & bioactive glass biomaterials are preferred over their counterparts as they have a high affinity to integrate with the surface material of the bone. However, polymer biomaterial segment is expected to witness the fastest CAGR from 2019 to 2025 owing to high usage of these materials for the reconstruction and fixation procedures of the spine, hip, and knee.

Orthopedic implants led the application segment in 2018 and are expected to remain dominant over the forecast period. Increasing number of trauma cases is one of the major factors driving the growth of this segment. Orthobiologics segment is anticipated to witness the fastest CAGR of 10.8% from 2019 to 2025. Increasing adoption of biomaterials in various orthobiologics for the treatment of spinal and other reconstructive surgeries is anticipated to drive the growth of this segment.

Led by U.S. North America led the market in 2018 owing to high demand for joint replacement/reconstruction, bone repair, and, other orthopedic procedures due to the presence of target population. Moreover, rise in the demand for advanced treatment options coupled with increasing awareness about bio-resorbable products is expected to drive the product demand in future.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/orthopedic-biomaterials-market

Further key findings from the study suggest:

North America accounted for the largest revenue share in 2018 owing to large patient pool and high awareness regarding the use of bio-resorbable biomaterials
Ceramics and bioactive glass segment led the market in 2018 owing to increased usage of these biomaterials for the restoration of damaged tissue and fixation surgeries and joint replacement surgeries
Orthopedic implants was the dominant application segment in 2018 due to an increased number of trauma cases worldwide
Some of the key companies in orthopedic biomaterials market are DSM Biomedical; Evonik Industries AG; Stryker Corp.; DePuy Synthes, Inc.; Zimmer Biomet; Invibio Ltd.; Globus Medical; Exactech, Inc.; Matexcel; AdvanSource Biomaterials Corp.; CAM Bioceramics B.V.; and Heraeus Holding

Vascular Grafts Market Size Worth $3.30 Billion By 2026

The global vascular grafts market size is projected to reach at USD 3.30 billion by 2026 expanding at a CAGR of 6.4%, according to a report by Grand View Research, Inc. Endovascular stent grafts dominated the market in 2018 and is expected to be the second fastest-growing segment over the forecast period. Increasing prevalence of cardiovascular aneurysms is the leading cause of rise in demand for endovascular stent grafts. Low levels of physical activity, sedentary lifestyle, and substance abuse are some of the key factors leading to the high prevalence of renal and Cardiac Diseases (CVDs) globally. The impact of these factors is especially high in developed economies, such as North America and Europe. However, it is expected to shift towards emerging regions, such as Asia Pacific and Latin America, owing to changing demographics.

Key factors attributed to higher impact in these countries are increasing prevalence of aforementioned diseases in geriatric population, rising disposable income, and changing lifestyle patterns. Polytetrafluoroethylene (PTFE) raw material segment led the global market in 2018 with a revenue of USD 710.3 million. The segment is anticipated to expand at the fastest CAGR over the forecast period on account of PTFE graft’s advantages, such as protection against delamination and minimal blood loss. Asia Pacific is expected to be the fastest-growing market with a CAGR of 7.5% over the forecast period due to increasing public and private healthcare expenditure and availability of healthcare insurance across urban and rural centers.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/vascular-graft-market

Further key findings from the study suggest:

Endovascular stent grafts led the market in 2018 as a result of increased prevalence of cardiac aneurysms caused due to sedentary lifestyle and other occupational factors
PTFE grafts led the raw materials segment in 2018 owing to their advantages, such as minimal blood loss and maximum protection against delamination
Moreover, technological advancements in PTFE-based products is anticipated to drive the segment further
North America was the dominant regional market with a revenue of USD 620.9 million owing to high prevalence of CVDs and kidney diseases
The region is projected to maintain the dominance in future due to the presence of advanced healthcare facilities and reimbursement policies
Some of the key companies in this market include Medtronic, plc; LeMaitre Vascular Inc.; Terumo Corp.; Getinge AB; W.L. Gore and Associates, Inc.; and Cook Medical, Inc.
These companies focus on technological innovations, new product launches, and regional expansion to gain a competitive edge

Moringa Products Market Worth $10.9 Billion By 2025

The global moringa products market size is expected to reach USD 10.9 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a CAGR of 10.4% over the forecast period. Growing need for nutritional supplements, improving health awareness among people, and shifting focus towards organic medication are the key factors for industry growth.

Increase in awareness among consumers regarding health benefits of moringa is one of the major reasons for the market growth. It has antifungal, antiviral, antidepressant, and anti-inflammatory properties, which are beneficial in healing various diseases. Additionally, it can be easily grown in tropical and subtropical regions with low cost, thereby resulting in increased usage of the plant in various applications. It is also one of the best products to treat malnutrition children younger than 3 years. Considering all these factors, demand for moringa is increasing in the market.

Moringa contains various healthful compounds such as vitamin A, vitamin B1, folate, calcium potassium, iron, and zinc. It is also extremely low in fats and contains no harmful cholesterol. The antibiotic and antibacterial properties of this plant may help inhibit the growth of various pathogens, and its high vitamin B content helps with digestion. Among all the vegetables, moringa is commonly used by South Indians for its flavor and delicious taste in Sambar and Curry preparation. Rising demand for the product due to its rich nutritional properties and low price is boosting the growth of this moringa products market.

Europe was the largest regional market in the year 2018 owing to growing demand for nutritional supplements. In 2018, U.S was the largest market with more than 75.0% share in North America. Rising awareness regarding organic health supplements is a major factor boosting the regional market growth. Growing trend of calorie reduction and weight management is also driving the regional market since moringa helps in reducing weight gain. Majority of the Americans prefer supplements over their daily diets. Moringa is an additional source of multivitamins, antioxidants, amino acids, and other nutrients. Due to all these health benefits, demand for this plant based product is rising among individuals, thereby boosting regional moringa products market growth.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/moringa-products-market

Further key findings from the study suggest:

The leaf powder segment is projected to expand at a CAGR of 11.2% over the forecast period
The online distribution channel will register the highest CAGR of 11.6% through 2025
U.S., China, Germany, Ethiopia, and Brazil are the major countries accounting for the largest market share in their respective regions.

Sunglasses Market Size Worth $17.0 Billion By 2025

The global sunglasses market size is expected to reach USD 17.0 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a CAGR of 2.3% over the forecast period. The market is expected to witness significant growth due to rising consumer preference for luxury and premium sunglasses, along with increasing disposable income.

Non-polarized sunglasses accounted for the largest market share in 2018 owing to easy availability and cheap pricing. Moreover, these sunglasses are available in many dark shades, which protect the eyes from the harmful sun rays. Polarized sunglasses are anticipated to expand at the highest CAGR of 2.6% from 2019 to 2025. Apart from providing 100% protection from the UV rays, these glasses also provide clear vision as compared to non-polarized glasses. Increasing awareness concerning eye health and harmful effects of sun rays and other emissions is expected to influence the consumer purchasing decision.

Offline distribution channel dominated the market in 2018. Many brands have their personalized stores worldwide to provide customer service and increase their distribution in the market. Customer preference to try out various pairs of sunglasses before purchasing is driving the market demand in this segment. Online distribution is expected to witness accelerated growth in the forecast period as manufacturers are increasing their advertising and promotional activities via digital channels. This distribution channel allows the manufacturers to reach out to a wider audience in less cost.

Europe held the largest market share in terms of revenue in 2018 due to the presence of major players and latest fashion trends followed in this region. Asia Pacific is anticipated to witness substantial growth due to increasing penetration of major brands in this region. Changing consumer preference driven by high disposable income is another factor propelling the market growth in this region.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/sunglasses-market

Further key findings from the report suggest:

In terms of revenue,online distribution channel is projected to expand at a CAGR of 2.5% over the forecast period
By product, the non-polarized segment dominated the market in 2018 owing to high visibility of the product in the emerging market
Europe held the largest sunglasses market share in 2018 owing to presence of major eyewear manufacturers in the region
The industry is highly competitive with a monopoly created by Luxottica Group. Various eyewear brands like Ray-Ban, Oakley, Sunglass Hut, Persol, and Vogue have been acquired by Luxottica to expand its brand portfolio in the market
In January 2017, Essilor, one of the major eyewear manufacturers, merged with Luxottica. This move was initiated to expand Luxottica’s brand portfolio and improve market penetration of Luxottica by leveraging Essilor’s target markets.

Seaweed Snacks Market Worth $3.36 Billion By 2027

The global seaweed snacks market size is expected to reach USD 3.36 billion by 2027 registering a CAGR of 10.8%, according to a new report by Grand View Research, Inc. The increasing demand for healthy snacks and better-for-you foods has been boosting the market growth. Seaweed is a rich source of vitamins, minerals, antioxidants, fiber, protein, iodine, amino acid, folic acid, calcium, omega-3 fatty acid, and potassium. These nutritional contents of seaweed products offer several health benefits, such as improved function of thyroid gland, enhanced gut health, and decreased cholesterol level. Furthermore, these products are naturally free from gluten, GMOs, and allergens, which also drives their demand. The strips & chips product segment dominated the market accounting for more than 50% share of the global revenue in 2019.

Nori strips and dried or roasted seaweed strips are the most common products in the market. These low-calorie and nutritious strips have become a healthy alternative to the high-calorie chips. Furthermore, the launch of various flavors, such as Korean BBQ, wasabi, sweet onion, teriyaki, and chili lime, is expected to expand the consumer base of the market in the upcoming years. Asia Pacific held the largest market share of over 50% in 2019 and will retain its dominant position throughout the forecast period as seaweed is one of the staple foods of Asian countries including China, South Korea, and Japan. However, North America is expected to register the fastest CAGR over the forecast period due to high product demand as a result of rising health concerns.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/seaweed-snacks-market

Further Key Findings from the Study Suggest:

North America is expected to register the fastest growth with a CAGR of 11.3% from 2020 to 2027 owing to the rising health concerns
The strips & chips product segment led the global market in 2019 and held over 50% of the global revenue share
Asia Pacific is estimated to be the largest regional market by 2027 due to the wide availability of raw materials
The online distribution channel segment is expected to register the fastest CAGR from 2020 to 2027 due to the increasing adoption of e-commerce across the globe

Dairy Products Market Size Worth $586.11 Billion By 2027

The global dairy products market size is anticipated to reach USD 586.11 billion by 2027, according to a new report by Grand View Research, Inc., expanding at a CAGR of 2.5% from 2020 to 2027. Rising demand for dairy products and growth of the modern retail and logistics facilities are some of the major factors driving the market growth. The rising popularity of innovative dairy products, such as low-fat butter, no-sugar flavored milk, and flavored cheese, is also driving the market. However, the rise of veganism and vegan diet, especially in North America and Europe, is expected to restrict market growth.

In terms of product, milk emerged as the largest segment in 2019 as it is considered an essential source of protein and calcium that helps in bone development. Moreover, milk products, such as flavored milk and low-fat milk, have higher demand. The online distribution channel segment is likely to ascend at the fastest CAGR over the forecast period as online platforms provide a wide range of products. In addition, such channels provide many discounts and cashback offers. The rising usage of the internet and improving online connectivity are expected to drive the segment growth further.

Asia Pacific is anticipated to emerge as the fastest-growing regional market from 2020 to 2027 due to the growing demand for cheese and yogurt in countries like China and India. The development of modern retail and logistics in these countries is also propelling the demand for dairy products. A busier lifestyle and a rising focus on health and wellness have resulted in the increased consumption of packaged dairy products. The trend is expected to grow significantly in the coming years, thereby supporting market growth. In addition, rapidly expanding e-commerce sector in the region due to increasing internet penetration and reliability is expected to boost product sales through online distribution channels.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/dairy-product-market

Further key findings from the report suggest:

In terms of product, the milk segment accounted for the largest revenue share of over 32% in 2019
Europe held the largest share of more than 31% in 2019 due to high consumption of cheese in countries including Germany, France, Italy, and Spain
Asia Pacific is projected to ascend at the fastest CAGR of 4.8% from 2020 to 2027 due to the rising demand for milk products in emerging economies including China, India, and Bangladesh